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Abstract
Background: Heat pretreatment of swine carotid artery has been shown to increase ser16-heat
shock protein 20 (HSP20) phosphorylation and suppress force, i.e., reduce force with only minimal
reduction in ser19-myosin regulatory light chain (MRLC) phosphorylation.
Results: We further investigated this response in intact histamine stimulated swine carotid artery
rings. There was a heat threshold such that increased ser16-HSP20 phosphorylation and force
suppression were observed between 43°C and 46°C. The increased ser16-HSP20 phosphorylation
persisted up to 16 hours after 44.5°C heat treatment. Pretreatment of swine carotid media at
44.5°C increased ser16-HSP20 phosphorylation without increases in [cAMP] or [cGMP], suggesting
an alternate mechanism, perhaps phosphatase inhibition, for the increase in ser16-HSP20
phosphorylation. Heat pretreatment at 47.5°C reduced force by decreasing MRLC
phosphorylation rather than by large increases in ser16-HSP20 phosphorylation. HSP20
phosphorylation at the putative PKC site did not change with any treatment.
Conclusion: These results demonstrate that multiple mechanisms can induce force suppression
that is correlated with ser16-HSP20 phosphorylation: 1) nitrovasodilators via cGMP, 2) forskolin
via cAMP, and 2) thermal stress in a cyclic nucleotide independent manner.
Background
There are three general mechanisms whereby vascular
smooth muscle force is regulated. 1) Activation mecha-
nisms involve contractile pathways that increase ser19-
myosin regulatory light chain (MRLC) phosphorylation,
either by increases in myoplasmic calcium ([Ca2+]i [1]) or
by decreases in myosin light chain phosphatase activity
[2]. The increased ser19-MRLC phosphorylation activates
the myosin's ATPase producing crossbridge cycling and
contraction. 2) Deactivation mechanisms are the reversal
of activation mechanisms: relaxation results from lower
ser19-MRLC phosphorylation induced by either reduc-
tions in [Ca2+] [3,4] or increases in myosin light chain
phosphatase activity [5]. Since dephosphoylated myosin
does not cycle, force is reduced. 3) Force suppression oc-
curs when force is reduced despite persistent elevation in
ser19-MRLC phosphorylation levels. This is an exception
to the above MRLC phosphorylation paradigm since
phosphorylated myosin should cycle and produce force.
Force suppression has been observed with elevations in
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with some pharmacologic treatments.
Cyclic nucleotide induced relaxation is associated with
phosphorylation of heat shock protein 20 (also known as
HSP20 or P20) on serine 16 [10–12]. More recently, ser16-
HSP20 phosphorylation was shown to specifically and
temporally correlate with "force suppression" rather than
the "deactivation" form of relaxation [8,10]. A region of
HSP20 (residues 110–121) has sequence homology with
troponin I; peptides from this region bound thin fila-
ments, reduced actin activated myosin S1 ATPase activity,
and relaxed skinned swine carotid artery [10]. We hypoth-
esized that binding of ser16-phosphorylated HSP20 to the
thin filament may "turn off" thin filaments so that phos-
phorylated myosin does not interact with the thin fila-
ment (i.e. a model similar to skeletal muscle troponin I).
This would explain low force with elevated MRLC phos-
phorylation. HSP20 has a second phosphorylation site,
presumptively phosphorylated by PKC [12], of unclear
significance.
HSP20 is a member of the heat shock protein superfamily
and is known to provide resistance to heat treatment in
cells [13]. Recently we found that heat pretreatment (4
hours at 44.5°C) of swine carotid artery increased ser16-
HSP20 phosphorylation and suppressed force [14]. In this
study, we addressed three questions: 1) What is the tem-
perature threshold for increases in ser16-HSP20 phospho-
rylation and force suppression? 2) Does the heat
pretreatment response diminish by prolonged recovery at
37°C after heat treatment, i.e. is the heat pretreatment re-
versible? And 3) Are increases in [cAMP] or [cGMP] re-




Tissues were first equilibrated at 37°C [15]. This involved
a "warm-up" 109 mM K+ contraction approximately 30
min after mounting, repeated stretching to ~1 × 105 N/m2
(~20 g for a 20 mg tissue), a release to ~0.2 × 105 N/m2
(~4 g), and a second 109 mM K+ contraction approxi-
mately 120 min after mounting. This protocol sets the
muscle to the optimal length for force generation. The lat-
ter K+ contraction was used for force normalization. Tis-
sues were then exposed to various temperatures for
various times (solutions were replaced if evaporation was
observed). Temperature was changed by adjusting the wa-
ter bath set point. This procedure increased temperature
within 5 min. Reducing temperature would have been
slower but was accelerated by adding ice to the water bath.
After the exposure to different temperatures, tissues were
returned to 37°C for various times, contracted with 10 µM
histamine for 10 min, and then frozen for analysis.
Threshold for temperature dependent increase in ser16-
HSP20 phosphorylation and force suppression
Equilibrated swine carotid medial rings were exposed to
various temperatures for 4 hours, returned to 37°C for 1
hour, contracted with 10 µM histamine for 10 min, and
then frozen. Significant reduction in force and increases in
ser16-HSP20 phosphorylation were observed with heat
treatments between 43°C and 46°C (Fig. 1). Ser19-MRLC
phosphorylation levels did not significantly differ in tis-
sues treated at 44.5°C or 37°C, suggesting that the de-
creased force observed at 44.5°C was force suppression.
Histamine did not induce any contraction after pretreat-
ment at 47.5°C, and histamine also did not significantly
increase ser19-MRLC phosphorylation levels (MRLC
phosphorylation was significantly less than that observed
at 37°C). This result suggests that the decreased force ob-
served at 47.5°C was caused by reduced ser19-MRLC
phosphorylation. Ser16-HSP20 phosphorylation at
47.5°C was significantly lower than that observed at
44.5°C but higher than that observed at 37°C. These data
suggest a biphasic response with ser16-HSP20 phosphor-
ylation-associated force suppression with heat pretreat-
ment between 43 and 46°C and deactivation by
inhibition of ser19-MRLC phosphorylation after heat pre-
treatment at 47.5°C.
Pretreatment at 2°C induced a small, insignificant in-
crease in ser16-HSP20 phosphorylation without signifi-
cant effects on force. Putative PKC-HSP20
phosphorylation [12] was not significantly altered at any
tested temperature.
Recovery after heat treatment
Swine carotid medial rings were exposed to 44.5°C for 4
hours, followed by 37°C for various times before stimula-
tion with 10 µM histamine for 10 min and freezing (Fig.
2). A set of control tissues were not exposed to 44.5°C and
had low ser16-HSP20 phosphorylation (labeled "before").
Ser16-HSP20 phosphorylation levels were high both in
tissues that were histamine stimulated at 44.5°C (0 time,
i.e. no recovery at 37°C) and in tissues that were returned
to 37°C for 15 min to 16 hours. Force was suppressed in
all heat-treated tissues regardless of recovery time. There
appeared to be a modest rebound in histamine-induced
contraction 1 to 8 hours after return to 37°C.
Dependence of histamine-induced force on ser16-HSP20 
phosphorylation
The relation between mean ser16-HSP20 phosphorylation
and mean force from all the tissues that were stimulated
with histamine is shown in the upper panel of Fig. 3.
There is a clear relation between reduced histamine-in-
duced force and increased ser16-HSP20 phosphorylation
with all treatments except the 47.5°C heat pretreatmentPage 2 of 9
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Threshold for temperature dependent increase in ser16-HSP20 phosphorylation and force suppression. Swine 
carotid artery tissues were exposed to various temperatures between 2°C and 47.5°C (shown on abscissa) for 4 hours, then 
returned to 37°C for 1 hour, and stimulated with 10 µM histamine for 10 min before freezing. Histamine induced ser16-HSP20 
phosphorylation (mol Pi at ser 16 / mol HSP20) is shown in the top panel, putative PKC-HSP20 phosphorylation (mol Pi at the 
PKC site / mol HSP20) in the second panel, ser19-MRLC phosphorylation (mol Pi at ser 19 / mol MRLC) in the third panel, and 
force in the bottom panel (n = 4–8, except n = 3 at 14 & 20°C and n = 2 at 8°C, data presented as mean ± 1 SEM). Ser19-
MRLC phosphorylation measurements were limited to tissues treated at 37°C, 44.5°C, and 47.5°C. Force was significantly 
reduced in tissues treated at 44.5°C or higher compared to 41.5°C or lower. Ser16-HSP20 phosphorylation was significantly 
higher in tissues treated between 43 and 46°C compared to tissues treated at less than 43°C or at 47.5°C. PKC-HSP20 phos-
phorylation did not significantly change. At temperatures between 43 and 46°C, low force was associated with elevated ser16-
HSP20 phosphorylation levels despite elevated ser19-MRLC phosphorylation levels. At 47.5°C, reduced force was associated 
with significantly reduced ser19-MRLC phosphorylation (compared to tissues treated at 37°C or 44.5°C, i.e. there was 
deactivation).Page 3 of 9
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Recovery after heat treatment. Swine carotid artery tissues were exposed to 44.5°C for 4 hours and then either 1) stim-
ulated with 10 µM histamine for 10 min before freezing (0 recovery time) or returned to 37°C for various times and then stim-
ulated with 10 µM histamine for 10 min before freezing (positive recovery times). A unheated control set of tissues was 
stimulated with 10 µM histamine for 10 min and frozen without 44.5°C heat treatment (labeled "before"). Histamine induced 
ser16-HSP20 phosphorylation (mol Pi at ser 16 / mol HSP20) is shown in the top panel, putative PKC-HSP20 phosphorylation 
(mol Pi at the PKC site / mol HSP20) in the center panel, and force in the bottom panel (n = 4–6). Force was significantly 
reduced in all heat treated tissues regardless of recovery time compared to the unheated control. Ser16-HSP20 phosphoryla-
tion was significantly higher in all heat treated tissues regardless of recovery time compared to unheated control.Page 4 of 9
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Dependence of contractile force on ser16-HSP20 and putative PKC-HSP20 phosphorylation in tissues maxi-
mally stimulated with histamine. Upper panel: Mean data demonstrate the relation between ser16-HSP20 phosphoryla-
tion (mol Pi at ser 16 / mol HSP20) and contractile stress for all tissues presented in Figs. 1 and 2. All tissues were stimulated 
with 10 µM histamine for 10 min. The tissues treated for 4 hours at 47.5°C are shown as an open symbol and is not included 
in the linear regression. All other tissues are shown as filled circles. Overall there was a good inverse correlation between 
ser16-HSP20 phosphorylation and contractile force with these heat pretreatment protocols (r2 = 0.90, solid line is regression 
line, dotted line are 95% confidence intervals). Lower panel. Mean data demonstrate the relation between putative PKC-
HSP20 phosphorylation (mol Pi at the PKC site / mol HSP20) and contractile stress. There was little relation between putative 
PKC-HSP20 phosphorylation and contractile force with these heat pretreatment protocols.Page 5 of 9
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en the lower ser19-MRLC phosphorylation (i.e. deactiva-
tion) observed after 47.5°C pretreatment. There was no
correlation between putative PKC-HSP20 phosphoryla-
tion and force (lower panel of Fig. 3).
Cyclic nucleotide levels did not correlate with heat induced 
ser16-HSP20 phosphorylation levels
Swine carotid medial rings were stimulated with 10 µM
histamine for 10 min either before (control) or at the end
of a 4 hour 44.5°C treatment. Heat pretreatment did not
significantly alter [cAMP] and [cGMP] levels despite sig-
nificantly increased ser16-HSP20 phosphorylation and
suppressed force. These data suggest that the increases in
ser16-HSP20 phosphorylation cannot be explained by el-
evated [cAMP] and [cGMP] levels after 4 hours of heat
pretreatment.
Discussion
Our prior study [14] found that 1) 44.5°C heat pretreat-
ment of swine carotid artery increased ser16-HSP20 phos-
phorylation and suppressed force, i.e., a reduction in force
without a significant reduction in MRLC phosphoryla-
tion. 2) The effects of heat pretreatment and nitroglycerin
were additive, both on increasing ser16-HSP20 phosphor-
ylation and suppressing force [14]. And 3) the relation be-
tween ser16-HSP20 phosphorylation and force was
similar with heat pretreatment and nitroglycerin, suggest-
ing a similar mechanism of action to suppress force [14].
The goal of this study was to extend our observations on
heat treatment. We found that temperatures between 43
and 46°C increased ser16-HSP20 phosphorylation and
suppressed force, i.e. reduced force without reductions in
ser19-MRLC phosphorylation (Fig. 1). Excepting the
47.5°C response, the relation between mean ser16-HSP20
phosphorylation and mean force was similar with all
treatments in these histamine stimulated tissues (top pan-
el, Fig. 3), consistent with the hypothesis that ser16-
HSP20 phosphorylation was mediating force
suppression.
No contraction was observed after pretreatment at
47.5°C, however, this was not force suppression since
MRLC phosphorylation was significantly reduced to near
basal levels for the swine carotid. This may explain why
the response observed after 47.5°C was not on the ser16-
HSP20 phosphorylation/force relation shown in Fig. 3.
This finding is consistent with the hypothesis that differ-
ent temperatures reduce force by different mechanisms.
For example, whole body hyperthermia at 41.5°C in-
duced apoptosis in rats [16] while exposure to 48°C re-
portedly induces necrosis in cultured cells [17]. The
similar temperature sensitivity of apoptosis and ser16-
HSP20 phosphorylation suggests the possibility of a role
for HSP20 in the promotion of or protection from apop-
tosis. It is possible that HSP20 induced force suppression
may be part of a protective response to moderate heat ex-
posure. In contrast, the absence of a contractile and MRLC
phosphorylation response after more extreme heat expo-
sure (47.5°C) may represent tissue necrosis.
There was no significant change in putative PKC-HSP20
phosphorylation [12] with any protocol. As a result there
was no correlation between putative PKC-HSP20 phos-
phorylation and force (lower panel of Fig. 3).
We also investigated whether the heat pretreatment re-
sponse was reversible. Ser16-HSP20 phosphorylation lev-
els remained elevated and overall force remained low up
to 16 hours after return of heat treated tissues to 37°C.
This suggests that the process that increases ser16-HSP20
phosphorylation is not reversible, at least in vitro. This
may indicate substantial tissue damage during the 4 hour
exposure at 44.5°C.
Finally, we found that the increases in ser16-HSP20 phos-
phorylation were not explained by increases in [cAMP] or
[cGMP] at the end of heat treatment (Fig. 4). This suggests
that some other mechanism keeps ser16-HSP20 phospho-
rylation at high levels. Considering that the increased
ser16-HSP20 phosphorylation remains elevated for 16
hours after return to 37°C, it is possible that heat treat-
ment is reducing HSP20 phosphatase activity.
Our experiments suggest that temperatures of 43°C and
above can alter arterial contractility. Such temperatures
can occur physiologically. Brooks, et. al. [18] exhaustively
exercised rats for 90 min on treadmills. Immediately after
exercise (not during), thermocouples were inserted into
thigh skeletal muscles and the rectum. They found an ini-
tial mean temperature of 44.1°C in skeletal muscle and
42.1°C rectally. Both temperatures fell exponentially with
rest after exercise. It is likely that muscle temperature ex-
ceeded 44.1°C for at least part of the 90 min exercise. This
suggests that profound exercise can increase regional tem-
perature to levels that could potentially induce ser16-
HSP20 phosphorylation and force suppression. Thermal
stress may bring about a resistance to contractile agonists,
which could have clinical significance in conditions such
as hyperthermia, and/or sepsis with vasodilatory shock.
Heat treatment may have effects on smooth muscle be-
yond contractility. Orihara et al. [19] reported that expo-
sure of vascular smooth muscle cells to 43°C for 2 hours
inhibited cell proliferation. Further work is required to as-
sess whether HSP20 is involved in this response.
These results also demonstrate that multiple mechanisms
can induce force suppression that is correlated with ser16-Page 6 of 9
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Cyclic nucleotide levels did not correlate with heat induced ser16-HSP20 phosphorylation levels. Swine carotid 
artery tissues were either 1) stimulated with 10 µM histamine for 10 min at 37°C or 2) 44.5°C for 4 hours and then stimulated 
with 10 µM histamine for 10 min at 44.5°C prior to freezing. Histamine induced [cGMP] is shown in the top panel, [cAMP] in 
the center panel, ser16-HSP20 phosphorylation (mol Pi at ser 16 / mol HSP20) in the third panel, and force in the bottom panel 
(n = 4, data presented as mean ± 1 SEM). The ser16-HSP20 phosphorylation data is from a second set of tissues treated identi-
cally (the ''before'' group from Fig. 2). Treatment at 44.5°C did not significantly alter [cAMP] and [cGMP] levels despite signifi-
cantly increasing ser16-HSP20 phosphorylation and suppressing histamine induced force.Page 7 of 9
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increases in cGMP by nitrovasodilators and cAMP by for-
skolin increase ser16-HSP20 phosphorylation and induce
force suppression [8]. Such results suggest that the corre-
lation between ser16-HSP20 phosphorylation and force
suppression is robust in the swine carotid stimulated with
10 µM histamine. However, it must be stressed that differ-
ent contractile conditions may be associated with differ-
ent relationships between ser16-HSP20 phosphorylation
and force given the multiple mechanisms whereby agents
can cause relaxation [3–5]. For example, smooth muscle
relaxation can occur by agents that reduce myoplasmic
Ca2+ by inducing hyperpolarization, reducing Ca2+ influx
without changes in membrane potential, increasing Ca2+
efflux, or by reducing Ca2+ release from the internal store.
The response can depend on the form of contractile acti-
vation, e.g. nitroglycerin reduces Ca2+ better after agonist
activation compared with K+ depolarization [20]. Com-
parison of ser16-HSP20 phosphorylation/force relation-
ships require careful analysis in comparison with ser19-
MRLC phosphorylation levels to clearly show that the




Swine common carotid arteries were obtained from a
slaughterhouse and transported at 0°C in physiological
salt solution (PSS). PSS contained (mM): NaCl, 140; KCl,
4.7; 3-[N-morpholino] propane sulfonic acid (MOPS) 5;
Na2HPO4, 1.2; CaCl2, 1.6; MgSO4, 1.2; D-glucose, 5.6;
pH adjusted to 7.4 at 37°C. Dissection of medial rings,
mounting and determination of the optimum length for
stress development at 37°C was performed as described
[21]. The carotid "ring" preparation differs in the method
of mounting from our prior heat study which employed
carotid "strips" [14]. The mounting procedure, rings vs.
strips does not alter the behavior of the carotid media in
tissue baths. The intimal surface was mechanically rubbed
to remove the endothelium.
Antibodies
Rabbit anti-HSP20 antibody was made commercially via
repeated injection of gel purified recombinant HSP20 (se-
quence confirmed by mass spectroscopy). After confirma-
tion of an antigenic response, serum was collected and
frozen for future use. Specificity was verified as described
[8].
Measurement of HSP20 and MRLC phosphorylation
Swine carotid arteries were first thermally and histamine
stimulated, followed by freezing in an acetone-dry ice
slurry [15]. After air drying, the tissues were homogenized
in a buffer (20 mg wet weight tissue/ml buffer) containing
1% SDS, 10% glycerol, and 1 mM dithiothreitol. Full
strength, half strength, and quarter strength dilutions of
samples were then separated on one-dimensional isoelec-
tric focusing gels (ampholytes were a 50:50 mixture of pI
4–6.5 and pI 5–8 for HSP20 and a 50:50 mixture of pI 4–
6.5 and pI 4.5–5.4 for MRLC), blotted to PVDF or nitro-
cellulose membranes, immunostained with our rabbit
polyclonal anti-HSP20 antibody (1:5000) or rabbit poly-
clonal anti-MRLC antibody (1:4000 in 1% bovine serum
albumin and 0.01% sodium azide), and detected with en-
hanced chemifluorescence (ECF) for HSP20 and en-
hanced chemiluminescence (ECL) for MRLC [22]. A
representative blot is shown in Fig. 5. The dilutions en-
sured that the detection system was in the linear range.
Immunoblots were scanned on a Molecular Dynamics
fluorimager.
Phosphorylation was determined by change in the isoe-
lectric point (pI) for each phosphorylation species. There
are two HSP20 phosphorylation sites in the swine carotid,
therefore, there are four immunoreactive species: unphos-
phorylated at pI 6.3 (top band in Fig. 5),
monophosphorylated on a putative protein kinase C
(PKC) site at pI 6.0 (second from the top band in Fig. 5),
monophosphorylated on ser16 at pI 5.9 (second from the
bottom band in Fig. 5), and diphosphorylated on both ser
16 and the putative PKC site at pI 5.7 (bottom band in Fig.
5). Phosphorylation at ser16 was confirmed by mass
Figure 5
Representative blot of HSP20 immunostaining. The 
left column is full strength homogenate, the center column 
half strength homogenate, and the right column quarter 
strength homogenate. The top band is unphosphorylated, the 
center doublet is PKC monophosphorylated on top and 
ser16 monophosphorylated on bottom, and the bottom band 
is diphosphorylated HSP20. Full Half Quarter strength 
homogenate Unphosphorylated HSP20 PKC monophosphor-
ylated HSP20 ser16 monophosphorylated HSP20 Diphospho-
rylated HSP20
    Full        Half     Quarter strength homogenate 
Unphosphorylated HSP20 
PKC monophosphorylated HSP20 
ser
16
 monophosphorylated HSP20 
Diphosphorylated HSP20 Page 8 of 9
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oratory. Ser16-HSP20 phosphorylation was reported as
the percent of ser16 monophosphorylated (pI 5.9) plus
diphosphorylated HSP20 (pI 5.7) in relation to the sum
of all four species.
Identification of the "PKC" site is putative and is best de-
scribed by Beall, et al. [12]. They found that phorbol dib-
utyrate induced phosphorylation in the C terminal region
of HSP20 based on tryptic digest analysis. We calculated
putative PKC-HSP20 phosphorylation as the percent of
putative PKC monophosphorylated HSP20 (pI 6.0) plus
diphosphorylated HSP20 (pI 5.7) in relation to the sum
of all species. For MRLC, phosphorylation was deter-
mined as the percent of phosphorylated smooth muscle
MRLC in relation to total smooth muscle MRLC (i.e. non-
muscle MRLC were ignored).
Cyclic nucleotide assays
[cAMP] and [cAMP] were determined by immunoassays
were performed in a separate set of tissues treated identi-
cally except the homogenization buffer was 0.1 M HCl
(detailed methods in [23]). Prior analyses showed the
sensitivity of these assays in carotis smooth muscle ho-
mogenates [23]. The University of Virginia Diabetes Core
lab performed the immunoassays with commercial
reagents.
Statistics
Data are presented in the text and figures as mean ± 1
SEM. Symbols without error bars reflect errors smaller
than the size of the symbol. Data were compared by ANO-
VA and Student-Newman-Keuls if n > 2 and Student's un-
paired t test if n = 2 with significance defined as p < 0.05.
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